SHERMAN STEVEN 4
4 · EKSO BIONICS HOLDINGS, INC. · Filed Oct 26, 2022
Insider Transaction Report
Form 4
SHERMAN STEVEN
Director
Transactions
- Exercise/Conversion
Common Stock
2022-10-21+15,600→ 704,151 total - Sale
Common Stock
2022-10-24$1.29/sh−5,921$7,619→ 698,230 total - Exercise/Conversion
Restricted Stock Units
2022-10-21−15,600→ 46,798 total→ Common Stock (15,600 underlying)
Footnotes (4)
- [F1]Represents shares sold by the Reporting Person on October 24, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the ninth installment of a restricted stock award originally reported by the Reporting Person in Form 4 filed with the Commission on March 10, 2022
- [F2]These shares were sold in a single transaction at a price of $1.2868 per share.
- [F3]The restricted stock units ("RSUs") were granted on March 8, 2022 in accordance with the terms of an Executive Employment Agreement entered into between the Reporting Person and the Company on January 21, 2022 (the "Effective Date").
- [F4]The RSUs vest in twelve equal installments on the first twelve monthly anniversaries of the Effective Date, starting February 21, 2022, such that the RSUs will be fully vested as of January 21, 2023. The ninth installment of RSUs vested on October 21, 2022 and were delivered to the Reporting Person upon settlement.